Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Diplomat Pharmacy, Inc. (NYSE: DPLO).

Full DD Report for DPLO

You must become a subscriber to view this report.


Recent News from (NYSE: DPLO)

TemperPack partners with Diplomat to bring curbside recyclable insulation to Life Science shipments
RICHMOND, Va. , Nov. 29, 2018 /PRNewswire/ -- Diplomat Pharmacy, the largest independent provider of specialty pharmacy services in the United States , has committed to moving their cold chain shipments away from EPS foam by utilizing TemperPack's ClimaCell™ insulating techno...
Source: PR Newswire
Date: November, 29 2018 13:34
Diplomat Selects Inovalon's Specialty Pharmacy Platform
BOWIE, Md., Nov. 28, 2018 (GLOBE NEWSWIRE) -- Inovalon (Nasdaq: INOV), a leading technology company providing advanced, cloud-based platforms empowering data-driven healthcare, today announced a multi-year deal with Diplomat (NYSE: DPLO), the nation’s largest independent provider of ...
Source: GlobeNewswire
Date: November, 28 2018 07:55
Diplomat Switches to Fully Recyclable Packaging for Temperature-Sensitive Medication
FLINT, Mich. , Nov. 26, 2018 /PRNewswire/ --  Diplomat Pharmacy, Inc. (NYSE: DPLO), is now shipping temperature-sensitive medication in ClimaCell™ coolers from TemperPack. ClimaCell coolers are fully recyclable at curbside and insulated with renewable materials tha...
Source: PR Newswire
Date: November, 26 2018 16:05
New Research Coverage Highlights Harmonic, ScanSource, Clean Energy Fuels, American Software, Diplomat Pharmacy, and Quidel - Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Harmonic Inc. (NASDAQ:HLIT), ScanSource, Inc. (NASDAQ:SCSC), Clean Ene...
Source: GlobeNewswire
Date: November, 09 2018 08:25
Diplomat Pharmacy 2018 Q3 - Results - Earnings Call Slides
The following slide deck was published by Diplomat Pharmacy in conjunction with their 2018 Q3 earnings Read more ...
Source: SeekingAlpha
Date: November, 07 2018 15:46
Diplomat Pharmacy down 32% after Q3 revenue miss and 83% drop in earnings
Diplomat Pharmacy ( DPLO -32.1% ) slumps on more than double normal volume following its Q3 report released after the close yesterday that included a revenue miss of $50M. Highlights: More news on: Diplomat Pharmacy, Healthcare stocks news, Earnings news and commentary, Stocks on the m...
Source: SeekingAlpha
Date: November, 07 2018 11:39
Diplomat Pharmacy, Inc. (DPLO) CEO Brian Griffin on Q3 2018 Results - Earnings Call Transcript
Diplomat Pharmacy, Inc. (DPLO) Q3 2018 Results Earnings Conference Call November 06, 2018 05:00 PM ET Executives Terri Anne Powers - VP, IR Brian Griffin - Chairman and CEO Joel Saban - President Atul Kavthekar - CFO Analysts Lisa Gill - JP Morgan Steven Valiquette - Ba...
Source: SeekingAlpha
Date: November, 06 2018 22:00
Diplomat Pharmacy EPS in-line, misses on revenue
Diplomat Pharmacy (NYSE: DPLO ): Q3 GAAP EPS of $0.00 in-line. More news on: Diplomat Pharmacy, Earnings news and commentary, Healthcare stocks news, Read more ...
Source: SeekingAlpha
Date: November, 06 2018 16:50
Diplomat Announces 3rd Quarter Financial Results
FLINT, Mich. , Nov. 6, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy services, announced financial results for the quarter ended September 30, 2018 . All comparisons, unless otherwise noted, are to the quar...
Source: PR Newswire
Date: November, 06 2018 16:15
Notable earnings after Tuesday's close
ACAD , AAXN , AIZ , APEI , ASH , BEL , BOLD , BWXT , CHUY , COHR , CPE , CSLT , CUTR , CWH , DAR , DATA , DIOD , DK , DOOR , DPLO , DVN , DXC , DXCM , EGN , ENLC , ENLK , ENPH , ETSY , EVH , EVRI , FANG , FIVN , FTK , FTR , G , GDDY , GHDX , GLUU , HAL...
Source: SeekingAlpha
Date: November, 05 2018 17:35

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-1419.2918.6119.3618.605856,564
2017-11-2716.9216.7117.0416.66819,628
2017-11-2417.3516.9717.3516.79448,301
2017-11-2217.1417.3217.5517.05866,538
2017-11-2116.1217.1717.2415.96481,132,123

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-121,40012,13011.5416Cover
2018-12-112,4046,68235.9773Short
2018-12-105,66813,33942.4919Short
2018-12-078,48137,19422.8021Cover
2018-12-066,6958,16881.9662Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on DPLO.


About Diplomat Pharmacy, Inc. (NYSE: DPLO)

Logo for Diplomat Pharmacy, Inc. (NYSE: DPLO)

Not available

 

Contact Information

 

 

Current Share Structure

  • Market Cap: $1,820,701,715 - 05/18/2018
  • Issue and Outstanding: 74,132,806 - 05/07/2018

 


Recent Filings from (NYSE: DPLO)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 07 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 06 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 27 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 15 2018
Statement of beneficial ownership of common stock by certain persons
Filing Type: SC 13GFiling Source: edgar
Filing Date: June, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 08 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 08 2018
Official notification to shareholders of matters to be brought to a vote (Proxy)
Filing Type: DEF 14AFiling Source: edgar
Filing Date: April, 30 2018
Automatic shelf registration statement of securities of well-known seasoned issuers
Filing Type: S-3ASRFiling Source: edgar
Filing Date: April, 06 2018

 

 


Daily Technical Chart for (NYSE: DPLO)

Daily Technical Chart for (NYSE: DPLO)


Stay tuned for daily updates and more on (NYSE: DPLO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NYSE: DPLO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in DPLO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of DPLO and does not buy, sell, or trade any shares of DPLO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/